REQUEST A DEMO
Total
USD $0.00
Search more companies

St Pharm Co., Ltd. (Siheung) (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: St Pharm Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

ST Pharm Co.,Ltd is a company that manufactures RNA based drugs and offers cGMP standard services for pharmaceutical product development and commercialization. The company provides gene therapy CDMO, oligonucleotide, and mRNA services, and has developed two mRNA platform technologies. With facilities in multiple countries, ST Pharm has a history of supporting oligonucleotide projects and has invested in technology platforms for mRNA therapeutics and vaccines.

Headquarters
231, Hyeopryeok-Ro, Siheung-Si, Gyeonggi-Do
Siheung; Gyeonggi;

Contact Details: Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.

Website: http://www.stpharm.co.kr

Basic Information
Total Employees:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Outstanding Shares:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Registered Capital:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Financial Auditors:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Incorporation Date:
August 18, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
32.7%
Purchase this report to view the information.
15.3%
Purchase this report to view the information.
6.4%
Company Performance
Financial values in the chart are available after St Pharm Co., Ltd. (Siheung) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-11.16%
Total operating revenue
-11.18%
Operating profit (EBIT)
N/A
EBITDA
-29.59%
Net Profit (Loss) for the Period
54.28%
Total assets
19.88%
Total equity
25.75%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
2.79%
Return on Equity (ROE)
0.28%
Debt to Equity Ratio
-4.7%
Quick Ratio
1.65%
Cash Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?